Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Sopheon PLC Issue of Equity 02/10/2017 7:00am UK Regulatory (RNS & others) Sopheon (LSE:SPE) Intraday Stock Chart Today : Monday 2 October 2017 Click Here for more Sopheon Charts. TIDMSPE RNS Number : 3154S Sopheon PLC 02 October 2017 For immediate release SOPHEON PLC ("Sopheon" or the "Company") Issue of Equity Sopheon, the international provider of software, expertise, and best practices for Enterprise Innovation Management, announces today that it has issued and allotted 10,000 ordinary shares of 20 pence each in the capital of the Company ("Ordinary Shares") in connection with the exercise of share options. Application has been made for the 10,000 new Ordinary Shares to be admitted to trading on AIM, and dealings are expected to commence on 3 October 2017. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 7,463,431. The Company does not hold any shares in treasury. Accordingly, the figure of 7,463,431 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules. Mvg Trinko
Toch vandaag 38k omzet met gelijkblijvende koers. Gr Arie de Beuker
Ja is niet veel qua omzet of wat?
Heb je helemaal gelijk in Harry, fijn weekend
zo is dat gart,mensen die geen soof aandelen hebben,kan je maar beter gelijk geven, tijd voor een pilsie:)
Vraag niet hoe het kan ..., maar als iemand een oorzaak heeft, mooi 7%.
Dan ook gewoon niet vragen:-)))
Oorzaak is simpelweg dat men graag aandeeltjes wil en denkt dat dat op korte termijn niet goedkoper kan. Waarom anders instappen op deze prijs? Ik zit al een tijd te wachten op een doorbraak, inmiddels gaan de ontwikkelingen bij Sopheon gewoon door. Alleen maar positief nieuws. Het bedrijf is nu grofweg 30 miljoen pond waard. Eens kijken of de koers nu wel doorzet..... Klaas
De directie heeft zelf wel vertrouwen:-)) Sopheon PLC Director/PDMR Shareholding 11/10/2017 10:44am UK Regulatory (RNS & others) Sopheon (LSE:SPE) Intraday Stock Chart Today : Wednesday 11 October 2017 Click Here for more Sopheon Charts. TIDMSPE RNS Number : 3174T Sopheon PLC 11 October 2017 For Immediate Release SOPHEON PLC ("Sopheon" or the "Company") DIRECTOR SHAREHOLDINGS Sopheon has been notified that certain directors of the Company have purchased shares in the Company. Barry Mence has purchased 3,000 ordinary shares of 20 pence each in the capital of the Company ("Ordinary Shares") in his Individual Savings Account ("ISA"). Barry Mence's spouse Maria Mence has purchased 2,750 Ordinary Shares in her ISA. The above shares were purchased at a price of GBP3.97 each. In addition, Barry Mence has transferred 2,000 Ordinary Shares from being held in his Self Invested Personal Pension ("SIPP") to his ISA, and he has also transferred 3,000 Ordinary Shares from being held in his SIPP to the ISA of Maria Mence. Barry Mence's total beneficial interest in Ordinary Shares, including those held by his wife, has accordingly increased by 5,750 Ordinary Shares to 1,458,326 Ordinary Shares. Stuart Silcock has purchased 625 Ordinary Shares in his dealing account. Stuart Silcock's spouse Christine Silcock has purchased 1,250 Ordinary Shares in her dealing account and a further 625 Ordinary Shares in her ISA. The above shares were purchased at a price of GBP3.97 each. In addition, Stuart Silcock has transferred 7,000 Ordinary Shares from being held in his SIPP to his ISA. Stuart Silcock's total beneficial interest in Ordinary Shares, including those of his wife, as well as his interest in Ordinary Shares held in Bare Trust for his grandchildren has accordingly increased by 2,500 Ordinary Shares to 279,627 Ordinary Shares. Trinko
mogge, dit is de 3de keer dat ze deze aantallen kopen,bestuurders + famillie, lijkt niet veel,maar dat 3keer doen ,kom je toch aan flinke aantallen,ze gaan echt niet kopen,als ze weten dat de nabije toekomst er slecht uit gaat zien, de voorzitter en zn bestuurders weten, natuurlijk veel meer dan ons, wat er allemaal nog komen gaat.
ik zeg wel mogge,het is middag onderhand.
Ik weet bijna zeker dat ze dividend gaan uitkeren. Let maar op. Het gaat gewoon goed met Sopheon anders kopen ze echt niet voor hun oude dag. Gr Arie de Beuker
Dividend mogen ze in hun bolle r..t stoppen, laten ze maar zorgen voor een overname prijs van 8 tot 10 euro;-))))
mogge,ja een overname ben ik ook voor, goed bod en het boek soof sluiten, we kunnen wel wachten tot sint juttemus,maar we worden ook een dagje ouder he, en die dividend zit ik ook niet op te wachten.
Hallootjes... Zit niet echt vaart in he..lage volumes..jojo een beetje rond de 4 euro.. Wordt het nog wat denkt iemand?
Sopheon Awarded Funding for European Research Projects Funding recognizes Sopheon’s ongoing contribution to research on market disruptors such as Internet of Things, real-time decision support, and advanced analytics embedded into business process Sopheon, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, today announced the award of European funding for innovative research in the framework of the EUREKA/ITEA research program alongside a consortium of project partners. The funding is for two different projects, Medolution and PARTNER. Both research projects focus on developing innovative and intelligent methods and software for real time handling of massive volumes of data across complex scenarios, with emphasis on the healthcare industry. Sopheon’s contribution to these projects focuses on applying the data-driven decision support capabilities of our Accolade® software. Sopheon benefits in return from the collaboration with project partners - research institutes and leading software companies such as Philips Healthcare, Atos/Bull, Siemens Healthcare, Barco, IMEC, KPN and NXP Semiconductors – to develop breakthrough capabilities for commercial application in our software. In the current digital age, organizations are looking for technologies that allow them to handle unprecedented amounts of information, with speed. This information is drawn from a very incoherent landscape of IT systems and sources, within as well as beyond the physical boundaries of the enterprise. The data to be handled comes from many different sources – structured and unstructured data; metadata from sensor data, images, video – and is reused in the context of big data analysis, internet of things (IoT) techniques, cloud services, etc. The Accolade software is able to interpret all of this data in real time, irrespective of source or format, based on rules and criteria defined by domain experts and within predefined best practice protocols that are managed by the Accolade system. Huub Rutten, VP Research and Application Development at Sopheon, stated: “For Sopheon the research is very applicable to our core enterprise innovation management clients and future product strategy. Our work in these projects positions us to develop relationships with some of the leading companies in the world for commercial leverage, and to develop innovative strategic technologies and applications for our target markets. Further, our research discoveries also have the potential to open new market segments for our application.” This award brings to a total of five the number of research grants awarded to Sopheon since 2009. Sopheon® and Accolade® are trademarks of Sopheonwww.sopheon.com/sopheon-awarded-fundi... Bertus S.
Dat is een mooie erkenning wederom. Ze blijven zich erg goed ontwikkelen. Healthcare is een grote markt, Sopheon's exposure daarin wordt alsmaar groter. Dat moet zijn vruchten gaan afwerpen, dat kan niet anders. Klaas
het soof gebouw moet onderhand,helemaal propvol zitten met gewonnen prijzen,nu de koers nog.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
882,63
+1,42%
EUR/USD
1,0694
-0,33%
FTSE 100
8.139,83
+0,75%
Germany40^
18.177,90
+1,45%
Gold spot
2.337,95
0,00%
NY-Nasdaq Composite
15.927,90
+2,03%
Stijgers
Dalers